Vir Biotechnology VIR
NASDAQ VIR
$11.18 +0.53 (+4.98%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Other financing activities (2022 - 2025)

Updated

Vir Biotechnology (VIR) recorded Other financing activities of -$2,000 in Q4 2025, compared with $13,000 a year earlier.

Analysis

Vir Biotechnology (VIR) Other financing activities (2022 - 2025) Analysis & Trends

For FY2025, Vir Biotechnology reported Other financing activities of -$361,000.

  • Across earlier years, Other financing activities came in at -$165,000 in FY2024, -$287,000 in FY2023 and -$260,000 in FY2022.
  • The Q4 2025 figure is the lowest quarterly Other financing activities since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vir Biotechnology 1.89 Bn 1.89 Bn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,000.00
Sep 30, 2025 1,000.00
Dec 31, 2024 13,000.00
Sep 30, 2024 -40,000.00
Jun 30, 2024 -138,000.00
Dec 31, 2023 -387,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 -260,000.00
API Access

Vir Biotechnology Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=VIR&period=max&api_key=YOUR_API_KEY